COVID-19 should be a methylene blue “promoter” [Carta] (2020)
Source: Brazilian Journal of Cardiovascular Surgery. Unidade: FMRP
Subjects: COVID-19, INFECÇÕES POR CORONAVIRUS, QUIMIOMETRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EVORA, Paulo Roberto Barbosa. COVID-19 should be a methylene blue “promoter” [Carta]. Brazilian Journal of Cardiovascular Surgery. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.21470/1678-9741-1-2020-0607. Acesso em: 06 ago. 2024. , 2020APA
Evora, P. R. B. (2020). COVID-19 should be a methylene blue “promoter” [Carta]. Brazilian Journal of Cardiovascular Surgery. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.21470/1678-9741-1-2020-0607NLM
Evora PRB. COVID-19 should be a methylene blue “promoter” [Carta] [Internet]. Brazilian Journal of Cardiovascular Surgery. 2020 ; 35( 4): 604-605.[citado 2024 ago. 06 ] Available from: https://doi.org/10.21470/1678-9741-1-2020-0607Vancouver
Evora PRB. COVID-19 should be a methylene blue “promoter” [Carta] [Internet]. Brazilian Journal of Cardiovascular Surgery. 2020 ; 35( 4): 604-605.[citado 2024 ago. 06 ] Available from: https://doi.org/10.21470/1678-9741-1-2020-0607
